Tower Research Capital LLC (Trc) Journey Medical Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Journey Medical Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,726 shares of DERM stock, worth $13,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,726
Previous 91
1796.7%
Holding current value
$13,704
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DERM
# of Institutions
69Shares Held
8.96MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$14.7 Million0.6% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.31MShares$10.4 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA971KShares$7.71 Million1.15% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.87 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA615KShares$4.88 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $92.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...